TI
BIOSW

Telemetry Investments’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Telemetry Investments’s Portfolio BIOSW Stock Details BIOSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$0 Hold
33,303
– – ﹤0.01% 187
2022
Q3 		$3K Hold
33,303
– – ﹤0.01% 166
2022
Q2 		$5K Hold
33,303
– – 0.01% 173
2022
Q1 		$7K Buy
+33,303
New +$8.65K 0.01% 165

Other funds holding BIOSW

MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Telemetry Investments's BIOSW Position: Q4 2022 in Review

Telemetry Investments held its BioPlus Acquisition Corp. Warrants (BIOSW) position steady in Q4 2022 at 33,303 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #187.

Telemetry Investments first reported a position in BIOSW in Q1 2022 and has held it in 4 quarters since. The position peaked at $7K in Q1 2022. 45 funds tracked by Wall St. Rank hold BIOSW as of Q4 2022.

  • Telemetry Investments held 33,303 shares of BioPlus Acquisition Corp. Warrants worth $0 as of Q4 2022.
  • Telemetry Investments left its BioPlus Acquisition Corp. Warrants share count unchanged in Q4 2022.
  • BioPlus Acquisition Corp. Warrants made up ﹤0.01% of Telemetry Investments's portfolio in Q4 2022, its #187 holding.
  • Telemetry Investments first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and has held it in 4 quarters since.
  • Telemetry Investments's BioPlus Acquisition Corp. Warrants position peaked at $7K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.